Clinical study on radiofrequency combined with ^(131)I therapy for dedifferentiated thyroid carcinomas
射频联合^(131)I治疗失分化甲状腺癌的临床研究(英文)
摘要
Objective:The aim of this study was to explore clinical efficiency of radio frequency combined with 131I therapy for dedifferentiated thyroid carcinoma.Methods:All patients have been treated by radiofrequency connected with 131I in 29 cases of dedifferentiated thyroid carcinoma which performed radionuclide imaging and Ig array of blood serum before and after therapy,respectively.Results:There were 4(4/29) positive cases of radionuclide imaging before treatment and 19(19/29) cases 2 weeks after therapy,25(25/29) cases of overall efficacy and 15(15/29) curative cases. Conclusion: Radiofrequency connected with 131I improve clinical efficacy of 131I treatment for dedifferentiated thyroid cancer of thyroid in view of higher absorbing 131I of thyroid cancerous cell.
参考文献13
-
1Smith VE,Read ML,Turnell AS,et al.A novel mechanism of sodium iodide symporter repression in differentiated thyroid cancer.J Cell Sci,2009,122:3393–3402..
-
2Hou SS,Wang H.Research progress of redifferentiation of dedifferentiated thyroid carcinoma.J Shanghai jiaotong Univ (Med Sci)(Chinese),2010,30:275–277.
-
3Foujilas C,Marakaki C,Sirmos N.Sodium-iodine symporter in thyroid,normal and cancer tissues and its relation to nuclear medicine and to gene cloning treatment.Hell J Nucl Med,2009,12:189–193.
-
4Sodré AK,Rubio IG,Galr?o AL,et al.Association of low sodium-Iodide symporter messenger ribonucleic acid expression in malignant thyroid nodules with increased intracellular protein staining.J Clin Endocrinol Metab,2008,93:4141–4145.
-
5Chinese Medical Association.Guideline of clinical technique and operationnuclear medicine part.Beijing:The People Military Medical Publishing Company,2004.175–181.
-
6Ma JH.Emphasis on reformation of evaluated treatment to solid tumorRECIST summary.Chin J Urol (Chinese),2006,27:77–79.
-
7Li W,Ain KB.Human sodium-iodide symporter (hNIS) gene expression is inhibited by a trans-active transcriptional repressor,NIS-repressor,containing PARP-1 in thyroid cancer cells.Endocr Relat Cancer,2010,17:383–398.
-
8Wan DS.Clinical oncology.Beijing:The Scientific Publishing Company (Chinese),2005.171–179.
-
9Wu HY,Zuo SY,Ma C,et al.Short-term overt hypothyroidism affect on lipids after thyroxine-withdrawal in patients with differentiated thyroid carcinoma.Chinese-German J Clin Oncol,2009,8:647–649.
-
10Qin GP,Ji XL.Melanotic medullary carcinoma of thyroid:a case report.Chinese-German J Clin Oncol,2010,9:677–679.
-
1张永安,聂品.鳜血清免疫球蛋白的分离纯化及其亚单位分子量的测定[J].水生生物学报,1998,22(2):192-194. 被引量：29
-
2张福淼,杨桂文,李国田,曹善东,安利国.鲈血清免疫球蛋白分离纯化及部分特性分析[J].动物学杂志,2004,39(5):9-12. 被引量：20
-
3张振蔚,张雪梅,吴华.放射性核素报告基因显像[J].中国医学科学院学报,2003,25(6):728-730. 被引量：3
-
4Scientific Reports:射频治疗能够改变癌细胞表型[J].现代生物医学进展,2015,15(30).
-
5Zhen Cheng,Xuefeng Ya,Xilin Sun,BaozhongShen,Sanjiv Sam Gambhir.Tumor Molecular Imaging with Nanoparticles[J].Engineering,2016,2(1):132-140. 被引量：3
-
6伊光辉,林天龙,熊邦喜,刘晓东,杨金先.斑点叉尾(鱼回)血清免疫球蛋白纯化及其结构分析[J].福建农业学报,2005,20(2):91-96. 被引量：10
-
7Tanyue Lijianhui Xumian Duj uan Zhaoxiaohong Niuxueqin Panyi.A Clinical Study on the Relatinship between Impairied Glucose Toleranec and Mild Cognitive Impairment[J].中国药理通讯,2007,24(2):57-57.
-
8Mingxia Sun,Liying Zhang,Shanying Chen,Xinyu Liu,Yan Liang,Xiaofei Shao,Hequn Zou.Clinical Study of Association of Hs-CRP with Obesity and Diabetes[J].器官移植内科学杂志,2014,9(4):134-146.
-
9孙军,高谦,聂品.四种方法对鲢血清免疫球蛋白的纯化及分子量测定[J].浙江大学学报（农业与生命科学版）,2005,31(4):487-492. 被引量：6
-
10王扬淦,陆再英,熊希凯,张艳.射频消融对心室肌细胞能量代谢酶系和Ca^（＋＋）－ATP酶影响的研究[J].中国组织化学与细胞化学杂志,1996,5(1):11-15. 被引量：2
